natgillin/translations-raw huggingface dataset:
4′-(bromomethyl)biphenyl-2-carbonitrile
4′-(brommetyl)bifenyl-2-karbonitril
4-chloro-1′-(4-methoxyphenyl)benzohydrazide
4-kloro-1′-(4-metoxifenyl)bensohydrazid
trans-2′-fluoro-4-hydroxychalcone O-[(Z)-2-(dimethylamino)ethyl]oxime–fumaric acid (2:1)
trans-2′-fluoro-4-hydroxichalkon-O-[(Z)-2-(dimetylamino)etyl]oxim–fumarsyra (2:1)
N′-alpha-(tert-butoxycarbonyl)-N′-omega-nitro-L-arginine
N′-alfa-(tert-butoxikarbonyl)-N′-omega-nitro-L-arginin
N′-alpha-(tert-butoxycarbonyl)-N-methoxy-N-methyl-N′-omega-nitro-L-argininamide
N′-alfa-(tert-butoxikarbonyl)-N-metoxi-N-metyl-N′-omega-nitro-L-argininamid
N,N′-bis(trifluoroacetyl)-DL-homocystine
N,N′-bis(trifluoroacetyl)-DL-homocystin
2,2′-dithiodibenzonitrile
2,2′-ditiodibensonitril
N,N′-[dithiobis(o-phenylenecarbonyl)]bis-L-isoleucine
N,N′-[ditiobis(o-fenylenkarbonyl)]bis-L-isoleucin
N,N-dimethyl-2-[4-(methylsulfanyl)phenoxy]benzylamine hydrochloride
N,N-dimetyl-2-[4-(metylsulfanyl)fenoxi]bensylaminhydroklorid
4′-demethylepipodophyllotoxin
4′-demetylepipodofyllotoxin
4′-(benzyloxycarbonyl)-4′-demethylepipodophyllotoxin
4′-(bensyloxikarbonyl)-4′-demetylepipodofyllotoxin
(25S)-cyclohexyl-25-de(sec-butyl)-5-demethoxy-5-oxo-22,23-dihydroavermectin A1a
(25S)-cyklohexyl-25-de(sek-butyl)- 5-demetoxi-5-oxo-22,23-dihydroavermektin A1a
N′1-methyl-1H-pyrazole-1-carboxamidine hydrochloride
N′1-metyl-1H-pyrazol-1-karboxamidinhydroklorid
(1R,2R,5S,6R)-2′,5′-dioxospiro[bicyclo[3.1.0]hexane-2,4′-imidazolidine]-6-carboxylic acid
(1R,2R,5S,6R)-2′,5′-dioxospiro[bicyklo[3.1.0]hexan-2,4′-imidazolidin]-6-karboxylsyra
2-butyl-4-chloro-1-[2′-(2-trityl-2H-tetrazol-5-yl)biphenyl-4-ylmethyl]-1H-imidazol-5-ylmethanol
2-butyl-4-kloro-1-[2′(2-trityl-2H-tetrazol-5-yl)bifenyl-4-ylmetyl]-1H-imidazol-5-ylmetanol
4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]biphenyl-2-carbonitrile
4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)metyl]bifenyl-2-karbonitril
11-ethyl-5-methyl-8-2-[(1-oxo-1λ4-quinolin-4-yl)oxy]ethyl-11H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6(5H)-one
11-etyl-5-metyl-8-2-[(1-oxo-1λ4-kinolin-4-yl)oxi]etyl-11H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6(5H)-on
(±)-1-azabicyclo[2.2.1]heptan-3-one
(±)-1-azabicyklo[2.2.1]heptan-3-on
3-ethyl 5-methyl (±)-4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dioxoisoindolin-2-yl)ethoxymethyl]pyridine-3,5-dicarboxylate
3-etyl-5-metyl (±)-4-(2-klorofenyl)-1,4-dihydro-2-[2-(1,3-dioxoisoindolin-2-yl)etoximetyl]pyridin-3,5-dikarboxylat
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-etyl-5-metyl 2-[(2-aminoetoxi)metyl]-4-(2-klorfenyl)-6-metyl-1,4-dihydropyridin-3,5-dikarboxylat
5,5-bis(4-pyridylmethyl)-5H-cyclopenta[2,1-b:3,4-b′]dipyridine hydrate
5,5-bis(4-pyridylmetyl)-5H-cyklopenta[2,1-b:3,4-b']dipyridinhydrat
(S)-1-2-[3-(3,4-dichlorophenyl)-1-(3-isopropoxyphenacyl)-3-piperidyl]ethyl-4-phenyl-1-azoniabicyclo[2.2.2]octane chloride
(S)-1-2-[3-(3,4-diklorofenyl)-1-(3-isopropoxifenacil)-3-piperidyl]etyl-4-fenyl-1-azoniabicyklo[2.2.2]oktanklorid
(S)-N-[4-(4-acetamido-4-phenyl-1-piperidyl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide-fumaric acid (1:1)
(S)-N-[4-(4-acetamido-4-fenyl-1-piperidyl)-2-(3,4-diklorofenyl)butyl]-N-metylbensamid–fumarsyra (1:1)
1-(4,4′-difluorobenzhydryl)piperazine
1-(4,4′-difluorobenshydryl)piperazin
4,6-dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidinyl
4,6-dikloro-5-(2-metoxifenoxi)-2,2'-bipyrimidinyl
(2R)-1-[4-((1aR,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl)piperazin-1-yl]-3-[(quinolin-5-yl)oxy]propan-2-ol trihydrochloride
(2R)-1-[4-((1aR,10bS)-1,1-difluor-1,1a,6,10b-tetrahydrodibenso[a,e]cyklopropa[c][7]annulen-6-yl)piperazin-1-yl]-3-[(kinolin-5-yl)oxi]propan-2-oltrihydroklorid
(2RS,3SR)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol–(1R,4S)-2-oxobornane-10-sulfonic acid (1:1)
(2RS,3SR)-2-(2,4-difluorofenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol–(1R,4S)-2-oxobornan-10-sulfonsyra(1:1)
8-chloro-5-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl)-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-klor-5-((4Z,7Z,10Z,13Z,16Z,19Z)-dokosa-4,7,10,13,16,19-hexaenoyl)-11-(4-metylpiperazin-1-yl)-5H-dibenso[b,e][1,4]diazepin
(±)-2-azabicyclo[2.2.1]hept-5-en-3-one
(±)-2-azabicyklo[2.2.1]hept-5-en-3-on
ethyl 3-(3-(S)-1-[4-(N′2-hydroxyamidino)phenyl]-2-oxopyrrolidin-3-ylureido)propionate
etyl-3-(3-(S)-1-[4-(N′2-hydroxiamidino)fenyl]-2-oxopyrrolidin-3-ylureido)propionat
2′,5-dichloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone
2',5-dikloro-2-(3-metyl-4H-1,2,4-triazol-4-yl)bensofenon
2′,5-dichloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]benzophenone
2-[3-(hydroximetyl)-5-metyl-4H-1,2,4-triazol-4-yl]-2',5-diklorobensofenon
2,4′-difluoro-2-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride
2,4′-difluoro-2-(1H-1,2,4-triazol-1-yl)acetofenonhydroklorid
N′6-trifluoroacetyl-L-lysyl-L-proline
N′6-trifluoroacetyl-L-lysyl-L-prolin
1-N′2-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-N′6-trifluoroacetyllysylproline
1-N′2-[(S)-1-etoxikarbonyl-3-fenylpropyl]-N′6-trifluoroacetyllysylprolin
N′6-trifluoroacetyl-L-lysyl-L-proline p-toluenesulfonate
N′6-trifluoroacetyl-L-lysyl-L-prolin-p-toluensulfonat
N′,N′-diethyl-2-methyl-N-(6-phenyl-5-propylpyridazin-3-yl)propane-1,2-diamine–fumaric acid (2:3)
N′,N′-dietyl-N-(6-fenyl-5-propylpyridazin-3-yl)-2-metylpropan-1,2-diamin–fumarsyra (2:3)
dibenzyl 5,5′-[(3,4-diethylpyrrole-2,5-diyl)bis(methylene)]bis[4-(3-methoxy-3-oxopropyl)-3-methylpyrrole-2-carboxylate]
dibensyl 5,5′-[(3,4-dietylpyrrol-2,5-diyl)bis(metylen)]bis[4-(3-metoxi-3-oxopropyl)-3-metylpyrrol-2-karboxylat]
5,5′-[(3,4-diethylpyrrole-2,5-diyl)bis(methylene)]bis[4-(3-hydroxypropyl)-3-methylpyrrole-2-carbaldehyde]
5,5′-[(3,4-dietylpyrrol-2,5-diyl)bis(metylen)]bis[4-(3-hydroxipropyl)-3-metylpyrrol-2-karbaldehyd]
1,4′-dimethyl-2′-propyl-1H,1′H-2,6′-bibenzimidazole
1,4′-dimetyl-2′-propyl-1H,1′H-2,6′-bibensimidazol
4-methyl-2-propylbenzimidazole-6-carboxylic acid
4-metyl-2-propylbensimidazol-6-karboxylsyra
N′-[N-methoxycarbonyl-L-valyl]-N-[(S)-3,3,3-trifluoro-1-isopropyl-2-oxopropyl]-L-prolinamide
N′-[N-metoxikarbonyl-L-valyl]-N-[(S)-3,3,3-trifluoro-1-isopropyl-2-oxopropyl]-L-prolinamid
2,2′-[(4-hydroxyphenyl)methylene]bis(4-(E)-[(5-methyl-1H-tetrazol-1-yl)imino]methylphenol)
2,2′-[(4-hydroxifenyl)metylen]bis(4-(E)-[(5-metyl-1H-tetrazol-1-yl)imino]metylfenol)
ethyl 1-methyl-5-[4′-(trifluoromethyl)biphenyl-2-carboxamido]indole-2-carboxylate
etyl 1-metyl-5-[4′-(trifluormetyl)bifenyl-2-karboxamido]indol-2-karboxylat
potassium 1-methyl-5-[4′-(trifluoromethyl)biphenyl-2-carboxamido]indole-2-carboxylate
kalium 1-metyl-5-[4′-(trifluormetyl)bifenyl-2-karboxamido]indol-2-karboxylat
O-[2-(2-amino-1,3-thiazol-4-yl)-2-((Z)-methoxyimino)acetyl] O,O-diethyl phosphorothioate
O-[2-(2-amino-1,3-tiazol-4-yl)-2-((Z)-metoxiimino)acetyl] O, O-dietyl-fosfortioat
O-(2-(2-aminothiazol-4-yl)-2-[1-(tert-butoxycarbonyl)-1-methylethoxy]iminoacetyl) O′,O′′-diethyl phosphorothioate
O-(2-(2-aminotiazol-4-yl)-2-[1-(tert-butoxikarbonyl)-1-metyletoxi]iminoacetyl) O′,O′′-dietylfosfortioat
cytidine 5′-(dihydrogen phosphate)
cytidin-5′-(divätefosfat)
2′,3′-dideoxyadenosine
2′,3′-dideoxiadenosin
inosine 5′-disodium phosphate
inosin-5′-dinatriumfosfat
3′-azido-3′-deoxy-5′-O-tritylthymidine
3′-azido-3′-deoxi-5′-O-trityltymidin
3′,5′-anhydrothymidine
3′,5′-anhydrotymidin
5′-O-tritylthymidine
5′-O-trityltymidin
(4S)-4,11-diethyl-4,9-dihydroxy-1H,12H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(4S)-4,11-dietyl-4,9-dihydroxi-1H,12H-pyran[3′,4′:6,7]indolizin[1,2-b]kinolin-3,14(4H,12H)-dion
2′-deoxy-5′-O-(4,4′-dimethoxytrityl)-N2-isobutyrylguanosine 3′-(2-cyanoethyl diisopropylphosphoramidite)
2′-deoxi-5′-O-(4,4′-dimetoxitrityl)-N2-isobutyrylguanosin-3′-(2-cyaoetyl-diisopropylfosforamidit)
2′-deoxy-5′-O-(4,4′-dimethoxytrityl)thymidine 3′-(2-cyanoethyl diisopropylphosphoramidite)
2′-deoxi-5′-O-(4,4′-dimetoxitrityl)tymidin-3′-(2-cyanetyldiisopropylfosforamidit)
N6-benzoyl-2′-deoxy-5′-O-(4,4′-dimethoxytrityl)adenosine 3′-(2-cyanoethyl diisopropylphosphoramidite)
N6-bensoyl-2′-deoxi-5′-O-(4,4'-dimetoxitrityl)adenosin-3′-(2-cyanetyldiisopropylfosforamidit)
N4-benzoyl-2′-deoxy-5′-O-(4,4′-dimethoxytrityl)cytidine 3′-(2-cyanoethyl diisopropylphosphoramidite)
N4-bensoyl-2′-deoxi-5′-O-(4,4′-dimetoxitrityl)cytidin-3′-(2-cyanetyl-diisopropylfosforamidit)
3′-O-mesyl-5′-O-tritylthymidine
3′-O-mesyl-5′-O-trityltymidin
3′-azido-2′,3′-dideoxy-5-methylcytidine hydrochloride
3′-azido-2′,3′-dideoxi-5-metylcytidinhydroklorid
2′-bromo-2′-deoxy-5-methyluridine 3′,5′-diacetate
2′-brom-2′-deoxi-5-metyluridin-3′,5′-diacetat
5′-benzoyl-2′,3′-didehydro-3′-deoxythymidine
5′-bensoyl-2′,3′-didehydro-3′-deoxitymidin
(3aS,8aR)-3-[(2R,4S)-2-benzyl-4,5-epoxyvaleryl]-2,2-dimethyl-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazole
(3aS,8aR)-3-[(2R,4S)-2-bensyl-4,5-epoxivaleryl]-2,2-dimetyl-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol
(5R)-9-chloro-5-ethyl-5-hydroxy-10-methyl-12-[(4-methylpiperidin-1-yl)methyl]-1,4,5,13-tetrahydro-3H,15H-oxepino[3′,4′:6,7]indolizino[1,2-b]quinoline-3,15-dione hydrochloride
(5R)-9-klor-5-etyl-5-hydroxi-10-metyl-12-[(4-metylpiperidin-1-yl)metyl]-1,4,5,13-tetrahydro-3H,15H-oxepino[3′,4′:6,7]indolizin[1,2-b]kinolin-3,15-dionhydroklorid
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol or apomorphine
(6aR)-6-metyl-5,6,6a,7-tetrahydro-4H-dibenso[de,g]kinolin-10,11-diol eller apomorfin
[(2-methyl-1-propionyloxypropoxy)(4-phenylbutyl)phosphinoyl]acetic acid-cinchonidine (1:1)
[(2-metyl-1-propionylpropoxi)(4-fenylbutyl)fosfinoyl]ättiksyra–cinkonidin (1:1)
benzyl 2,6-dimethoxy-4-(5R,5aR,8aR,9S)-6-oxo-9-[(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)oxy]-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-ylphenyl carbonate
bensyl 2,6-dimetoxi-4-(5R,5aR,8aR,9S)-6-oxo-9-[(2,3,4,6-tetra-O-bensyl-β-D-glukopyranosyl)oxi]-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]nafto[2,3-d][1,3]dioxol-5-ylfenylkarbonat
(5S,5aS,9S)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl 2,3-di-O-benzyl-4,6-O-[(1R)-ethylidene]-β-D-glucopyranoside
(5S,5aS,9S)-9-(4-hydroxi-3,5-dimetoxifenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]nafto[2,3-d][1,3]dioxol-5-yl 2,3-di-O-bensyl-4,6-O-[(1R)-etyliden]-β-D-glukopyranosid
1-(28-O-D-apio-beta-D-furanosyl-(1,3)-O-beta-D-xylopyranosyl-(1,4)-O-6-deoxy-alpha-L-mannopyranosyl)-(1,2)-4-O-[5-(5-alpha-L-arabinofuranosyloxy-3-hydroxy-6-methyloctanoyloxy)-3-hydroxy-6-methyloctanoyl]-6-deoxy-beta-D-galactopyranosyloxy-16-alpha-hydroxy-23-beta,28-dioxoolean-12-en-3-beta-yl)-O-beta-D-galactopyranosyl-(1,2)-O-beta-D-xylopyranosyl-(1,3)-beta-D-glucopyranosiduronic acid
1-(28-O-D-apio-beta-D-furanosyl-(1,3)-O-beta-D-xylopyranosyl-(1,4)-O-6-deoxi-alfa-L-mannopyranosyl)-(1,2)-4-O-[5-(5-alfa-L-arabinofuranosyloxi-3-hydroxi-6-metyloctanoyloxi)-3-hydroxi-6-metyloctanoyl]-6-deoxi-beta–D-galaktopyranosyloxi-16-alfa-hydroxi-23-beta,28-dioxoolean-12-en-3-beta-yl)-O-beta-D-galaktopyranosyl–(1,2)-O-beta-D-xylopyranosyl-(1,3)-beta-D-glukopyranosiduronsyra
Intermediate concentrate obtained from a genetically modified E. coli fermentation medium, containing human granulocyte-macrophage colony-stimulating factor; for use in the manufacture of medicaments of HS heading 3002
Intermediärkoncentrat framställt av substrat från fermentering av genetiskt modifierat E. coli som innehåller en faktor som stimulerar humana granulocyt-makrofag-kolonier, för tillverkning av medikament med HS-nr 3002
potassium clavulanate–silicon dioxide (1:1)
kaliumklavulanat–sackaros (1:1)
potassium clavulanate–sucrose (1:1)
kaliumklavulanat–silikondioxid (1:1)
Meat graded “Canada A”, “Canada AA”, “Canada AAA”, “Canada Choice” and “Canada Prime”, “A1”, “A2” and “A3”, according to the Canadian Food Inspection Agency — Government of Canada, corresponds to this definition’
Kött som ingår i klass Canada A, Canada AA, Canada AAA, Canada Choice och Canada Prime, A1, A2 och A3, enligt de normer som ställts upp av den kanadensiska regeringens livsmedelsbyrå (l'Agence Canadienne d'inspection des aliments du Gouvernement du Canada), motsvarar denna definition”
Boneless high-quality meat of bovine animals, fresh, chilled or frozen, meeting the following definition: ‘Selected cuts obtained from steers or heifers having been exclusively fed with pasture grass since their weaning.
Benfritt kött av nötkreatur eller andra oxdjur, av hög kvalitet, färskt, kylt eller fryst, och som motsvarar följande definition: ”Utvalda styckningsdelar av stutar eller kvigor som efter avvänjningen uteslutande har fötts upp på gräs från betesmark.
Other 800 t
Andra 800 t
See order No 107
Se löpnr 107
Indonesia 825000 t
Indonesien 825000 t
Other GATT countries, other than Thailand, China and Indonesia 145590 t
Andra Gatt-länder utom Thailand, Kina och Indonesien 145590 t
China 350000 t
Kina 350000 t
Non-GATT countries 32000 t (*)
Länder som inte omfattas av Gatt-avtalet 32000 t (*)
Other 2378387 t
Andra 2378387 t
Brazil 310124 t
Brasilien 310124 t
Other 336876 t
Andra 336876 t
India 10000 t
Indien 10000 t
ACP countries 1294700 t
AVS-länderna 1294700 t
(List of denaturants)
(förteckning över denatureringsmedel)
Birds’ eggs, not in shell, and egg yolks, fresh, dried, cooked by steaming or by boiling in water, moulded, frozen or otherwise preserved, whether or not containing added sugar or other sweetening matter
Fågelägg utan skal samt äggula, färska, torkade, ångkokta eller kokta i vatten, gjutna, frysta eller på annat sätt konserverade, även försatta med socker eller annat sötningsmedel:
Colour index [130]
Färgindex [130]
Sodium salt of 4-sulphobenzeneazo-resorcinol, or 2,4-dihydroxyazobenzene-4-sulphonic acid (colour: yellow)
Natriumsalt av 4-sulfobensenazoresorcinol eller 2,4-dihydroxiazobensen-4-sulfonsyra (färg: gul)
Fast yellow AB
Fast yellow AB
Each photocopy shall indicate the name and address of the consignee and be marked in red ‘Extract valid for… kg’ (in figures and letters) together with the place and date of the splitting.
I varje fotokopia ska följande anges: varupartimottagarens namn och adress, uppgiften ”Utdrag giltigt för … kg” i röd skrift (kvantiteten ska anges med siffror och bokstäver), uppdelningsort och uppdelningsdag.
List of bodies which may endorse certificates [131]CN code
Förteckning över organ som är behöriga att påteckna intyg [131]Varor som omfattas av KN-nr
Entry-Exit Inspection Quarantine Bureau, Shanghai, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Shanghai (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Shandong, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Shandong (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Hubei, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Hubei (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Liaoning, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Liaoning (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Yunnan, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Yunnan (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Hainan, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Hainan (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Inner Mongolia, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Inner Mongolia (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau Beijing, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Beijing (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau Chongqing, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Chongqing (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Fujian, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Fujian (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Gansu, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Gansu (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Guangxi, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Guangxi (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Guizhou, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Guizhou (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Hebei, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Hebei (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Henan, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Henan (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau Hunan, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Hunan (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Jiangsu, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Jiangsu (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Jiangxi, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Jiangxi (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Jilin, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Jilin (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Zhejiang, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Zhejiang (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Ningxia, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Ningxia (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Qinghai, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Qinghai (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Shaanxi, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Shaanxi (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Shanxi, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Shanxi (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine, Bureau Guangdong, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Guangdong (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Sichuan, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Sichuan (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Tianjin, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Tianjin (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Tibet, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Tibet (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Xinjiang, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Xinjiang (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Zhuhai Guangdong, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Zhuhai Guangdong (eller deras behöriga kontor)
Entry-Exit Inspection Quarantine Bureau, Heilongjiang, or its authorised offices
Entry-Exit Inspection Quarantine Bureau, Heilongjiang (eller deras behöriga kontor)
BilI of lading
Konossement
Entry under this subheading is subject to the presentation of a certificate of authenticity issued in accordance with the conditions laid down in Commission Regulation (EEC) No 139/81 (OJ L 15, 17.1.1981, p. 4).
För tillämpning av detta nummer erfordras att ett äkthetsintyg företes, utfärdat enligt de villkor som stadgas i kommissionens förordning (EEG) nr 139/81 (EGT L 15, 17.1.1981, s. 4).
Customs duty autonomously suspended, for an indefinite period, for ‘aircraft ground maintenance simulators, for civil use’ (TARIC code 9023008010).Entry under this subheading is subject to the conditions laid down in the relevant Community provisions (see Articles 291 to 300 of Commission Regulation (EEC) No 2454/93 (OJ L 253, 11.10.1993, p. 1)).
Autonom tullfrihet gäller tills vidare för ”simulatorer för markunderhåll av luftfartyg, för civilt bruk” (Taric-nummer 9023008010).För tillämpning av detta nummer erfordras att villkoren i särskilda gemenskapsbestämmelser är uppfyllda (se artiklarna 291 till 300 i kommissionens förordning (EEG) nr 2454/93 [EGT L 253, 11.10.1993, s. 1]).
The rules for the application of the entry price for fruit and vegetables are laid down in Regulation (EC) No 1580/2007 (OJ L 350, 31.12.2007, p. 1).
Reglerna för tillämpning av införselpriset för frukt och grönsaker fastställs i kommissionens förordning (EG) nr 1580/2007 (EUT L 350, 31.12.2007, s. 1).
This suspension of customs duty is subject to the conditions laid down in the relevant Community provisions being met (see Articles 291 to 300 of Commission Regulation (EEC) No 2454/93 (OJ L 253, 11.10.1993, p. 1)).
Detta upphävande ska förutsätta att villkoren i relevant gemenskapslagstiftning är uppfyllda (se artiklarna 291 till 300 i kommissionens förordning (EEG) nr 2454/93 [EGT L 253, 11.10.1993, s. 1]).
They can be preceded by a multiplying prefix such as bi, bis, di, hemi, hepta, hexa, mono, penta, sesqui, tetra, tri, tris, … (for example, diacetate).
De kan föregås av prefix av typen bi, bis, di, hemi, hepta, hexa, mono, penta, sesqui, tetra, tri, tris… (t.ex. diacetat).
2,2′-ethene-1,2-diylbis (5-aminobenzene-1-sulfonate) (INNCN)
2,2′-eten-1,2-diylbis(5-aminobensen-1-sulfonat) (INNCN)
N,N′-dibenzylethylenediammonium
N,N′-dibenzyletylendiammonium
Intermediate concentrate obtained from a genetically modified E. coli fermentation medium, containing human interferon alpha-2b; for use in the manufacture of medicaments of HS heading 3002
Intermediärkoncentrat framställt av substrat från fermentering av genetiskt modifierat E. coli som innehåller humant interferon alfa-2b, för tillverkning av medikament med HS-nr 3002
SE-11298 Stockholm
SE-112 98 Stockholm
SE-10451 Stockholm
SE-104 51 Stockholm
California Department of Food and Agriculturale, Division of Inspection Services, Shipping Point Inspection Sacramento, CA
California Department of Food and Agriculture, Division of Inspection Services, Shipping Point Inspection Sacramento, CA
For the purposes of this test, substances necessary for the cross-linking, such as vulcanising activators or accelerators, may be added; the presence of substances as provided for by note 5(B)(2) and (3) is also permitted. However, the presence of any substances not necessary for the cross-linking, such as extenders, plasticisers and fillers, is not permitted;
Förekomst av ämnen som avses i anmärkning 5 B) 2) och 3) är också tillåten, men förekomst av ämnen som inte är nödvändiga för bryggbindningen, såsom utdrygningsmedel, mjukningsmedel och fyllmedel, är inte tillåten,
217500-96-4 tulathromycin A + 280755-12-6 tulath. B tulathromycin
mikafungin
waste pharmaceuticals, that is, pharmaceutical products which are unfit for their original intended purpose due to, for example, expiry of shelf life; and (l) appliances identifiable for ostomy use, that is, colostomy, ileostomy and urostomy pouches cut to shape and their adhesive wafers or faceplates.
Artiklar, igenkännliga för att användas för stomier, nämligen anatomiskt utformade påsar för kolostomi, ileostomi och urostomi samt basplattor (adhesive wafers or faceplates) till sådana påsar.
SI-1523 Ljubljana
1523 Ljubljana
Corrigendum to Commission Regulation (EU) No 861/2010 of 5 October 2010 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff
Rättelse till kommissionens förordning (EU) nr 861/2010 av den 5 oktober 2010 om ändring av bilaga I till rådets förordning (EEG) nr 2658/87 om tulltaxe- och statistiknomenklaturen och om Gemensamma tulltaxan
(Official Journal of the European Union L 284 of 29 October 2010)
(Europeiska unionens officiella tidning L 284 av den 29 oktober 2010)
On page 191, CN code 26209920, column 2:
På sidan 699, KN-nummer 28444030, CAS RN 476413-07-7, tredje kolumnen, ska det
‘Containing mainly niobium and tantalum’,
”yttrium (90Y) takatuzumabtetraxetan”
‘Containing mainly niobium or tantalum’.
”yttrium (90Y) takatuzumab tetraxetan”.
Commission Regulation (EU) No 863/2010
Kommissionens förordning (EU) nr 863/2010
of 29 September 2010
av den 29 september 2010